Leiomyosarcoma laboratory tests: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Sunny Kumar (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
== Overview: == | |||
There are no specific laboratory findings associated with Leiomyosarcoma. | |||
== Lab test: == | |||
There are no specific laboratory findings associated with Leiomyosarcoma. <ref name="pmid18217961">Hoskins PJ, Le N (2008) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=18217961 Preoperative tumor markers at diagnosis in women with malignant mixed müllerian tumors/carcinosarcoma of the uterus.] ''Int J Gynecol Cancer'' 18 (6):1200-1. [http://dx.doi.org/10.1111/j.1525-1438.2007.01187.x DOI:10.1111/j.1525-1438.2007.01187.x] PMID: [https://pubmed.gov/18217961 18217961]</ref>However, we may find elevated levels of CA 125 and LDH( isozymes) in women with uterine sarcoma.However,usefulness of these markers are still being investigated.<ref name="pmid12144683">Goto A, Takeuchi S, Sugimura K, Maruo T (2002) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=12144683 Usefulness of Gd-DTPA contrast-enhanced dynamic MRI and serum determination of LDH and its isozymes in the differential diagnosis of leiomyosarcoma from degenerated leiomyoma of the uterus.] ''Int J Gynecol Cancer'' 12 (4):354-61. PMID: [https://pubmed.gov/12144683 12144683]</ref> | There are no specific laboratory findings associated with Leiomyosarcoma. <ref name="pmid18217961">Hoskins PJ, Le N (2008) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=18217961 Preoperative tumor markers at diagnosis in women with malignant mixed müllerian tumors/carcinosarcoma of the uterus.] ''Int J Gynecol Cancer'' 18 (6):1200-1. [http://dx.doi.org/10.1111/j.1525-1438.2007.01187.x DOI:10.1111/j.1525-1438.2007.01187.x] PMID: [https://pubmed.gov/18217961 18217961]</ref>However, we may find elevated levels of CA 125 and LDH( isozymes) in women with uterine sarcoma.However,usefulness of these markers are still being investigated.<ref name="pmid12144683">Goto A, Takeuchi S, Sugimura K, Maruo T (2002) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=12144683 Usefulness of Gd-DTPA contrast-enhanced dynamic MRI and serum determination of LDH and its isozymes in the differential diagnosis of leiomyosarcoma from degenerated leiomyoma of the uterus.] ''Int J Gynecol Cancer'' 12 (4):354-61. PMID: [https://pubmed.gov/12144683 12144683]</ref> | ||
Revision as of 00:20, 23 June 2018
Overview:
There are no specific laboratory findings associated with Leiomyosarcoma.
Lab test:
There are no specific laboratory findings associated with Leiomyosarcoma. [1]However, we may find elevated levels of CA 125 and LDH( isozymes) in women with uterine sarcoma.However,usefulness of these markers are still being investigated.[2]
|
Leiomyosarcoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Leiomyosarcoma laboratory tests On the Web |
|
American Roentgen Ray Society Images of Leiomyosarcoma laboratory tests |
|
Risk calculators and risk factors for Leiomyosarcoma laboratory tests |
References
- ↑ Hoskins PJ, Le N (2008) Preoperative tumor markers at diagnosis in women with malignant mixed müllerian tumors/carcinosarcoma of the uterus. Int J Gynecol Cancer 18 (6):1200-1. DOI:10.1111/j.1525-1438.2007.01187.x PMID: 18217961
- ↑ Goto A, Takeuchi S, Sugimura K, Maruo T (2002) Usefulness of Gd-DTPA contrast-enhanced dynamic MRI and serum determination of LDH and its isozymes in the differential diagnosis of leiomyosarcoma from degenerated leiomyoma of the uterus. Int J Gynecol Cancer 12 (4):354-61. PMID: 12144683